| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |